Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location
Toxicologic Pathology · 2023
DOI: 10.1177/01926233231168133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, 2023. Verfasst von Renee R Hukkanen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Amgen Inc., Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Pathology, Peer Review. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Toxicologic/veterinary pathologists are working remotely from Good Laboratory Practice (GLP) test facilities (TFs) in increasing numbers, most commonly in home-office settings. A study pathologist (SP) generating data on GLP-compliant nonclinical studies must be keenly aware of applicable national GLP regulations and comply with TF and protocol requirements. This Toxicological Pathology Forum Opinion Piece will summarize primary areas of emphasis for the SP generating GLP data using glass slides. Peer review and digital review of whole slide images are out of scope for this opinion piece. Key GLP considerations for primary pathology on glass slides are discussed with respect to SP location and employment status, including pathologist qualifications, specimen management, facilities, equipment, archive, and quality assurance. Notable differences between national GLP regulations of the United States, the United Kingdom, Germany, the Netherlands, France, Ireland, Switzerland, Italy, and Israel are presented. With the understanding that each combination of location and employment is unique, the authors provide a general overview of considerations for successful remote GLP work.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amgen Inc., Cambridge, Massachusetts, USA.
- Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
- LabCorp Early Development Laboratories Inc., Madison, Wisconsin, USA.
- Toxicology & Pathology Consulting, LLC, Hillsborough, North Carolina, USA.
- European Research Biology Center, Rome, Italy.
- Consultant, Wuelfrath, Germany.
ORCID-Profile: Renee R Hukkanen, Matthias Rinke, Alys E Bradley, Barb Munch
Zitieren
APA
Hukkanen, R. R., Trapani, M., Derringer, T., Laast, V., Wojcinski, Z. W., Manno, R. A., Rinke, M., van Esch, E., Bradley, A. E., Cristofori, P., Alison, R., & Munch, B. (2023). Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location. Toxicologic Pathology. https://doi.org/10.1177/01926233231168133
Vancouver
Hukkanen RR, Trapani M, Derringer T, Laast V, Wojcinski ZW, Manno RA, et al. Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location. Toxicologic Pathology. 2023. doi:10.1177/01926233231168133
BibTeX
@article{Hukkanen2023,
author = {Hukkanen, Renee R and Trapani, Michelle and Derringer, Tana and Laast, Victoria and Wojcinski, Zbigniew W and Manno, Rosa Anna and Rinke, Matthias and van Esch, Eric and Bradley, Alys E and Cristofori, Patrizia and Alison, Roger and Munch, Barb},
title = {Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location},
journal = {Toxicologic Pathology},
year = {2023},
doi = {10.1177/01926233231168133}
}
EUVIMED